Screening, Imaging, and Image-Guided Biopsy Techniques for Breast Cancer

Surgical Clinics of North America

Volumn 93, Issue 2, 2013, Pages 309-327

  Smetherman, Dana H ^a  

^a OCHSNER CLINIC FOUNDATION   (United States)

Author keywords

Breast MRI; Breast ultrasonography; Mammography; Screening

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GADOLINIUM; TECHNETIUM 99M;

BREAST CANCER; BREAST CARCINOMA; BREAST EXAMINATION; BREAST SPECIFIC GAMMA IMAGING; CANCER DIAGNOSIS; CANCER RISK; CANCER SCREENING; CANCER STAGING; CANCER SURGERY; COMPUTER ASSISTED RADIOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIGITAL BREAST TOMOSYNTHESIS; ECHOMAMMOGRAPHY; ELASTOGRAPHY; FINE NEEDLE ASPIRATION BIOPSY; FULL FIELD DIGITAL MAMMOGRAPHY; HUMAN; IMAGE GUIDED BIOPSY; INTRADUCTAL CARCINOMA; MAMMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; POSITRON EMISSION MAMMOGRAPHY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECURRENT CANCER; REVIEW; SENSITIVITY AND SPECIFICITY; THREE DIMENSIONAL IMAGING; TREATMENT RESPONSE;

BIOPSY, NEEDLE; BREAST NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; IMAGE-GUIDED BIOPSY; MAGNETIC RESONANCE IMAGING; MAMMOGRAPHY; POSITRON-EMISSION TOMOGRAPHY; PRACTICE GUIDELINES AS TOPIC; ULTRASONOGRAPHY, MAMMARY; UNITED STATES;

EID: 84875307597     PISSN: 00396109     EISSN: 15583171     Source Type: Journal    
DOI: 10.1016/j.suc.2013.01.004     Document Type: Review

References (55)

1. Schnitt S.J., Connolly J.L., Recht A., et al. Breast relapse following primary radiation therapy for early breast cancer. II. Detection, pathologic features and prognostic significance. Int J Radiat Oncol Biol Phys 1985, 11:1277-1284.
2. Bartelink H., Borger J.H., van Dongen J.A., et al. The impact of tumor size and histology on local control after breast conserving treatment. Radiother Oncol 1988, 11:297-303.
3. Bedrosian I., Mick R., Orel S.G., et al. Changes in the surgical management of patients with breast carcinoma based on preoperative magnetic resonance imaging. Cancer 2003, 98:468-473.
4. Liberman L., Morris E.A., Kim C.M., et al. MR imaging findings in the contralateral breast of women with recently diagnosed breast cancer. AJR Am J Roentgenol 2003, 180:333-341.
5. Lehman C.D., Gatsonis C., Kuhl C.K., ACRIN Trial 6667 Investigators Group, et al. MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med 2007, 356(13):1295-1303.
6. Morrow M. Magnetic resonance imaging in the pre-operative evaluation breast cancer: primum non nocere. J Am Coll Surg 2004, 198:240-241.
7. Morrow M. Magnetic resonance imaging in breast cancer: one step forward, two steps back?. JAMA 2004, 292:2779-2780.
8. Morrow M. Magnetic resonance imaging in breast cancer: is seeing always believing?. Eur J Cancer 2005, 41:1368-1369.
9. Warren Burhenne L.J., Wood S.A., D'Orsi C.J., et al. Potential contribution of computer-aided detection to the sensitivity of screening mammography. Radiology 2000, 215(2):554-562.
10. Brem R.F., Baum J., Lechnter M., et al. Improvement in sensitivity of screening mammography with computer-aided detection: a multi-institutional trial. AJR Am J Roentgenol 2003, 181(3):687-693.
11. Birdwell R.L., Ikeda D.M., O'Shaughnessy K.F., et al. Mammographic characteristics of 115 missed cancers later detected with screening mammography and the potential utility of computer-aided detection. Radiology 2001, 219(1):192-202.
12. Freer T.W., Ulissey M.J. Screening mammography with computer-aided detection: prospective study of 12,860 patients in a community breast center. Radiology 2001, 220(3):781-786.
13. Gilbert F.J., Astley S.M., McGee M.A., et al. Single reading with computer-aided detection and double reading of screening mammograms in the United Kingdom National Breast Screening Program. Radiology 2006, 241(1):47-53.
14. Ikeda D.M., Birdwell R.L., O'Shaugnessy K.F., et al. Analysis of 172 subtle findings on prior mammograms in women with breast cancer detected at follow-up screening. Radiology 2003, 226(2):494-503.
15. Fenton J.J., Taplin S.H., Carney P.A., et al. Influence of computer-aided detection on performance of screening mammography. N Engl J Med 2007, 356:1399-1409.
16. Lillie-Blanton M. Mammography Quality Standards Act: x-ray quality improved, access unaffected, but impact on health outcomes unknown: testimony before the Subcommittee on Health and the Environment, Committee on Commerce, House of Representatives 1998, Committee on Commerce, Washington, DC.
17. American College of Radiology Breast imaging reporting and data system (BI-RADS) 2003, American College of Radiology, Reston (VA). 4th edition.
18. Pisano E.D., Gastonis C., Hendrick E., et al. Diagnostic performance of digital versus film mammography for breast cancer screening - the results of the American College of Radiology Network (ACRIN) Digital Mammographic Imaging Screening Trial (DMIST). N Engl J Med 2005, 353(17):1773-1783.
19. MQSA National Statistics. Available at:. Accessed June 1, 2012. http://www.fda.gov/.
20. Schnall M.D., Blume J., Bluemke D.A., et al. Diagnostic architectural and dynamic features at breast MR imaging: multicenter study. Radiology 2006, 238:42-53.
21. Lee C.H. Problem solving MR imaging of the breast. Radiol Clin North Am 2004, 42:919-934.
22. Bluemke D.A., Gatsonis C.A., Chen M.H., et al. Magnetic resonance imaging of the breast prior to biopsy. JAMA 2004, 292:2735-2742.
23. Ikeda D.M., Birdwell R.L., Daniel B.L. Potential role of magnetic resonance imaging and other modalities in ductal carcinoma in situ detection. Magn Reson Imaging Clin N Am 2001, 9:345-356. vii.
24. Hylton N.M., Blume J.D., Bemreuter W.K., et al. Locally advanced breast cancer: MR imaging for prediction of response to neoadjuvant chemotherapy - results from ACRIN 6657/I-SPY trial. Radiology 2012, 263:663-672.
25. Poplack S.P., Tosteson T.D., Kogel C.A., et al. Digital breast tomosynthesis: initial experience in 98 women with abnormal digital screening mammography. AJR Am J Roentgenol 2007, 189(3):616-623.
26. Dromain C., Thibault F., Muller S., et al. Dual-energy contrast-enhanced digital mammography: initial clinical results. Eur Radiol 2011, 21:565-574.
27. Hruska C.B., Boughey J.C., Phillips S.W., et al. Scientific Impact Recognition Award: molecular breast imaging: a review of the Mayo Clinic experience. Am J Surg 2008, 196:470-476.
28. Brem R.F., Floerke A.C., Rapelyea J.A., et al. Breast-specific gamma imaging as an adjunct imaging modality for the diagnosis of breast cancer. Radiology 2008, 247:651-657.
29. Brem R.F., Shahan C., Rapelyea J.A., et al. Detection of occult foci of breast cancer using breast-specific gamma imaging in women with one mammographic or clinically suspicious breast lesion. Acad Radiol 2010, 17:735-743.
30. Berg W.A., Weinberg I.N., Narayannan D., et al. High-resolution fluorodeoxyglucose positron emissions tomography with compression (" positron emission mammography") is highly accurate in depicting primary breast cancer. Breast J 2006, 12:309-323.
31. Berg W.A., Madsen K.S., Schilling K., et al. Breast cancer: comparative effectiveness of positron emission mammography and MR imaging in presurgical planning for the ipsilateral breast. Radiology 2011, 258:59-72.
32. Hellquist B.N., Duffy S.W., Abdsaleh S., et al. Effective of population-based service screening with mammography for women ages 40 to 49 years: evaluation of the Swedish Mammography Screening in Young Women (SCRY) cohort. Cancer 2011, 117(4):714-722.
33. Tabar L., Yen M.F., Vitak B., et al. Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening. Lancet 2003, 361:1405-1410.
34. Gotzsche P.C., Olsen O. Is screening for breast cancer with mammography justifiable?. Lancet 2000, 355:129-134.
35. U.S.Preventive Services Task Force Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2009, 151:716-726.
36. Coldman A., Philips N., Warren L., et al. Breast cancer mortality after screening in British Columbia women. Int J Cancer 2007, 120:1076-1080.
37. Hendrick R.E., Helvie M.A. Mammography screening: a new estimate of number needed to screen to prevent one breast cancer. AJR Am J Roentgenol 2012, 198(3):723-728.
38. Wang A, van Houten H, Fan J, et al. Impact of the United States Preventive Services Task Force Update for breast cancer screening on utilization of mammography in women under 50. Academy Health Annual Research Meeting. Orlando, June 24-26, 2012.
39. Harvey J.A., Fajardo L.L., Innis C.A. Previous mammograms in patients with impalpable breast carcinoma: retrospective vs. blinded interpretation. AJR Am J Roentgenol 1993, 161:1167-1172.
40. Feig S.A., Shaber G.S., Patchefsky A., et al. Analysis of clinically occult and mammographic occult breast tumors. AJR Am J Roentgenol 1977, 128:403-408.
41. Wallis M.G., Walsh M.T., Lee J.R. Review of false negative mammography in a symptomatic population. Clin Radiol 1991, 44:13-15.
42. Martin J.E., Moskowtiz M., Milbrath J.R. Breast cancer missed by mammography. AJR Am J Roentgenol 1979, 132:737-739.
43. Cahill C.J., Boulter P.S., Gibbs N.M., et al. Features of mammographically negative breast tumours. Br J Surg 1981, 68:883-884.
44. Mann B.D., Giuliano A.E., Bassett L.W., et al. Delayed diagnosis of breast cancer as a result of normal mammograms. Arch Surg 1983, 118:23-24.
45. Bird R.E., Wallace T.W., Yankaskas B.C. Analysis of cancers missed at screening mammography. Radiology 1992, 184:613-617.
46. Kalisher L. Factors influencing false negative rates in xeromammography. Radiology 1979, 133:297-301.
47. Goerge S.K., Evans J., Cohen G.P., et al. Characteristics of breast carcinomas missed by screening radiologists. Radiology 1997, 204:131-135.
48. Holland R., Hendriks J.H., Mravunac M. Mammographically occult breast cancer: a pathologic and radiologic study. Cancer 1983, 52:1810-1819.
49. Boyd N.F., Martin L.J., Bronskill M., et al. Breast tissue composition and susceptibility to breast cancer. J Natl Cancer Inst 2010, 102(16):1224-1237.
50. Carney P.A., Miglioretti D.L., Yankaskas B.C., et al. Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med 2003, 138(3):168-175.
51. Rosenberg R.D., Hunt W.C., Williamson M.R., et al. Effects of age, breast density, ethnicity, and estrogen replacement therapy on screening mammographic sensitivity and cancer stage at diagnosis: review of 183,134 screening mammograms in Albuquerque, New Mexico. Radiology 1998, 209(2):511-518.
52. Kerlikowske K., Grady D., Barclay J., et al. Likelihood ratios for modern screening mammography. Risk of breast cancer based on age and mammographic interpretation. JAMA 1996, 276(1):39-43.
53. Berg W.A., Blume J.D., Cormack J.B., ACRIN 6666 Investigators, et al. Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. JAMA 2008, 299(18):2151-2163.
54. Berg W.A., Zheng Z., Lehrer D., et al. Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk. JAMA 2012, 307(13):1394-1404.
55. Saslow D., Boetes C., Burke W., et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 2007, 57(2):75-89.